Jane Street’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
Other funds holding CTXR
MFS
XT
AAG
BW
Jane Street's CTXR Position: Q2 2026 in Review
Jane Street increased its Citius Pharmaceuticals (CTXR) stake by 445% in Q2 2026, buying an estimated $67.9K and bringing the position to 122,837 shares worth $74.3K. The position accounts for ﹤0.01% of the portfolio, ranked #10761.
Jane Street first reported a position in CTXR in Q4 2019 and has held it in 15 quarters since. The position peaked at $288K in Q1 2023. 43 funds tracked by Wall St. Rank hold CTXR as of Q2 2026.
- Jane Street held 122,837 shares of Citius Pharmaceuticals worth $74.3K as of Q2 2026.
- Jane Street bought 100,314 Citius Pharmaceuticals shares in Q2 2026, an estimated $67.9K.
- Citius Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10761 holding.
- Jane Street first reported a position in Citius Pharmaceuticals in Q4 2019 and has held it in 15 quarters since.
- Jane Street's Citius Pharmaceuticals position peaked at $288K in Q1 2023.
- 43 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.